Research Article
ALDH1 Cancer Stem Cell Marker as a Prognostic Factor in Triple-Negative Breast Cancer
| Variables | Total | Percentage |
| Age | ≥50 years | 25 | 46.30 | <50 years | 29 | 53.70 |
| Tumor size (T) | 1 | 2 | 3.70 | 2 | 14 | 25.93 | 3 | 14 | 25.93 | 4 | 24 | 44.44 |
| Involvement of lymph nodes (N) | 0 | 15 | 27.78 | 1 | 31 | 57.41 | 2 | 4 | 7.41 | 3 | 4 | 7.41 |
| Remote metastasis (M) | Negative | 39 | 72.22 | Positive | 15 | 27.78 |
| Histological grading | 1 | 2 | 3.70 | 2 | 28 | 51.85 | 3 | 24 | 44.44 |
| Ki67 | <20% | 9 | 16.67 | ≥20% | 45 | 83.33 |
| Staging | 1 | 1 | 1.85 | 2 | 19 | 35.19 | 3 | 19 | 35.19 | 4 | 15 | 27.78 |
| Chemotherapy | TC | 26 | 48.15 | CAF/CEF | 25 | 46.30 | Others | 3 | 5.56 |
| Recurrence | Negative | 46 | 85.19 | Positive | 8 | 14.81 |
| Radiotherapy | Negative | 23 | 42.59 | Positive | 31 | 57.41 |
| ALDH1 | Positive | 21 | 38.89 | Negative | 33 | 61.11 |
|
|